Tulosta

ADHD-kyselylomakkeet WURS, BADDS ja BRIEF-A aikuisilla

Lisätietoa aiheesta
8.2.2017
Maarit Virta ja Sami Leppämäki

WURS

BADDS

BRIEF-A

Kirjallisuutta

  1. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885-90 «PMID: 8494063»PubMed
  2. Das D, Vélez JI, Acosta MT ym. Retrospective assessment of childhood ADHD symptoms for diagnosis in adults: validity of a short 8-item version of the Wender-Utah Rating Scale. Atten Defic Hyperact Disord 2016;8:215-223 «PMID: 27510231»PubMed
  3. Wood DR, Reimherr FW, Wender PH ym. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry 1976;33:1453-60 «PMID: 793563»PubMed
  4. Kivisaari S, Laasonen M, Leppämäki S ym. Retrospective assessment of ADHD symptoms in childhood: discriminatory validity of Finnish translation of the Wender Utah Rating Scale. J Atten Disord 2012;16:449-59 «PMID: 22286113»PubMed
  5. Brown TE. Brown Attention-Deficit Disorder Scales for Adolescents and Adults. San Antonio, TX: The Psychological Corporation 1996
  6. Brown TE. Executive functions and attention deficit hyperactivity disorder: implications of two conflicting views. International Journal of Disability, Development and Education 2006;53:35-46
  7. Roth RM, Isquith PK, Gioia GA. Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A). FL, USA: Psychological Assessment Resources 2005
  8. Grane VA, Endestad T, Pinto AF ym. Attentional control and subjective executive function in treatment-naive adults with Attention Deficit Hyperactivity Disorder. PLoS One 2014;9:e115227 «PMID: 25545156»PubMed
  9. Dupaul GJ, Weyandt LL, Rossi JS ym. Double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with ADHD. J Atten Disord 2012;16:202-20 «PMID: 22166471»PubMed
  10. Adler L, Tanaka Y, Williams D ym. Executive function in adults with attention-deficit/hyperactivity disorder during treatment with atomoxetine in a randomized, placebo-controlled, withdrawal study. J Clin Psychopharmacol 2014;34:461-6 «PMID: 24977716»PubMed
Käypä hoito -suositukset ovat riippumattomia, tutkimusnäyttöön perustuvia kansallisia hoitosuosituksia. Lue lisää
LINKKIEN TYYPIT JA VÄRIKOODIT
Kirjallisuusviite
Kuva
Linkki toiselle sivustolle
Lisätietoa
Näytönastekatsaus
PDF-tiedosto
PubMed-abstrakti
Taulukko